Sten Vermund,
M.D., Ph.D.
 

Sten  has been a steadfast member of the SAB since  the year 2000 and wrote a letter of support for the R21 grant. As an epidemiologist, he has always been intrigued by the observation of the relatively low prevalence of HIV/AIDS in Jamaica and the widespread use of cannabis in the at-risk population despite the increase in other sexually transmitted diseases. 

​

He is fully supportive of the transition to the treatment of the genitourinary syndrome of menopause since this population, which is at increased risk of HIV acquisition, will benefit from the increased barrier function that the drug promotes.  

More Information